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Abstract
Aims/Hypothesis. Indo-Asian immigrants in The Hague,
The Netherlands, have a nearly 40-fold higher risk of
end-stage diabetic nephropathy compared to the Cauca-
sian population. To detect a genetic susceptibility for
nephropathy within the Indo-Asian population, we as-
sessed whether familial clustering of nephropathy oc-
curs in families of Indo-Asian Type 2 diabetic patients.
Methods. We compared nephropathy prevalence be-
tween two groups of first-degree relatives of Indo-
Asian patients with Type 2 diabetes; the first group
(case relatives) consisted of 169 relatives of patients
with end-stage diabetic nephropathy; the second group
(control relatives) consisted of 161 relatives of diabet-
ic patients who had no nephropathy. The case and
control relatives were examined for diabetes, blood
pressure, renal function, microalbuminuria and urine
dipstick mcasurcmcnts.
Results. The mean age was 41 years and similar in
the case and control relatives. Diabetes was distrib-
uted equally in both family groups. We did not
find more nephropathy in first-degree relatives of
Indo-Asian Type 2 diabetic patients with end-stage
diabetic nephropathy in comparison with the control-
relatives.
Conclusion/interpretation. We could not detect a ge-
netic susceptibility for diabetic nephropathy within the
Indo-Asian population. The lack of familial clustering
of renal disease in Indo-Asian diabetic patients points
to a general genetic or environmental susceptibility
for diabetic nephropathy in this population. [Dia-
betologia (2003) 46:618-624]
Keywords Albuminuria, genetics, diabetic nephropa-
thy, ethnology, Indo-Asian, Asian, Indian, epidemiolo-
gy, proteinuria, non insulin-dependent diabetes, DM
Type 2.
Familial clustering of diabetic nephropathy was first
described in Type l diabetic patients.fl] Later, cluster-
ing was also observed in Type 2 diabetic patients. A
familial predisposition for diabetic nephropathy was
observed in different ethnic groups like the American
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Pima Indians, Afro-Americans, Brazilian and Italian
Type 2 diabetic patients.[2, 3, 4, 5, 6, 7]. These obser-
vations are consistent with the hypothesis of a genetic
susceptibility in the pathogenesis of diabetic nephrop-
athy.
Indo-Asian people from Surinam are originally de-
scended from the Indian subcontinent, including India,
Pakistan, and Bangladesh. In a recent study, Indo-
Asian patients were found to have a close to 40-fold
increased risk for end-stage diabetic nephropathy in
comparison to native Caucasians [8]. Studies carried
out in the United Kingdom showed comparable results
[9, 10]. This is higher than expected since the preva-
lence of Type 2 diabetes was only eight times higher
in the Indo-Asian population, again in comparison
with the Caucasian native population [11]. An expla-
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nation for this relatively higher incidence of diabetic
nephropathy could be an additional genetic suscepti-
bility to develop nephropathy within the Indo-Asian
population. This might be detected by the presence of
familial clustering of nephropathy in relatives of pa-
tients with diabetic nephropathy, but specific family
studies for nephropathy are lacking in the Indo-Asian
population. However, a small case-control family
study in South India showed higher rates of protein-
uria in siblings of Type 2 diabetic patients with neph-
ropathy in comparison with age-, sex- and diabetic
duration-matched siblings of control patients without
diabetic nephropathy [12].
The aim of our study was to investigate whether fa-
milial clustering of nephropathy occurs in first degree
relatives of Type 2 diabetic Indo-Asian patients with
and without nephropathy. We tried to prevent selec-
tion bias by a population-based study design and the




We evaluated the predisposition for nephropathy among Indo-
Asian first degree relatives of Type 2 diabetic patients with
end-stage renal failure (case-relatives). They were compared
with first-degree relatives of Indo-Asian Type 2 diabetic pa-
tients who had no clinical signs of diabetic nephropathy (con-
trol-relatives). The case and control relatives were invited for
an assessment between September Ist, 1998 and December
31 st, 2000.
The study protocol was approved by the Institutional Medi-
cal Ethics Comtnittee in accordance with the Declaration of
Helsinki.
Subjects
Case-families. The case-index patients were recruited from the
records of the dialysis units of three regional hospitals, which
together represent the total dialysis capacity in the town of The
Hague. Included were all patients first registered between 1990
and 1999 for dialysis because of end-stage renal failure attrib-
uted to Type 2 diabetes; patients were considered to have Type
2 diabetes if they used oral anti-diabetic medication prior to di-
alysis, or if their fasting C-peptide concentrations were indica-
tive of Type 2 diabetes. Indo-Asian dialysis patients were ini-
tially identified by their surnames. If the patients were alive,
we visited them in the dialysis unit and confirmed their ethnic
origin. A standardized interview was taken with respect to dia-
betes and family history äs well äs demographic parameters.
After informed consent, we contacted their first-degree rela-
tives living in the Netherlands (parents, siblings and children).
If the case-index patient had died, we contacted the relatives
with the help of the general practitioner (GP) of the deceased
patient.
Control families. Control-index patients with Type 2 diabetes
were selected with the help of general practitioners of the in-
cluded case-index patients. For each case-index patient includ-
ed, one Indo-Asian control-index was chosen at random among
the patients with Type 2 diabetes from the records of the GP;
control-index patients were eligible if they were of the same
sex äs the case-index and had no microalbuminuria. To ensure
random sampling, we went through all the records of that GP,
and made a numbered list of all eligible indo-Asian Type 2 pa-
tients. Subsequently, control-index patients were drawn from
this list by use of a random number table. Another source of
control-index patients were the spouses of the investigated rel-
atives. If the spouse had Type 2 diabetes mellitus and no mi-
croalbuminuria, we invited the siblings and parents of the
spouse for the investigation. The control-index patients were
also invited through a letter for a visit at our outpatient's re-
search unit. A few days later they were contacted by phone to
obtain informed consent and to make an appointment at our
research outpatient clinic.
Inclusion of the family relatives. All first-degree relatives
(father, mother, siblings, and children) of the case and control
index patients living in the Netherlands were invited äs part
of a family investigation for diabetes and renal disease. We in-
vited the case and control relatives randomly throughout the
investigation period. Relatives who were pregnant were invited
later on, three months after they gave birth. Patients younger
than 16 years were not included. We tried to avoid appoint-
ments during the menstrual period of women.
Procedures and measurements
The family relatives came during the morning hours, after
fasting for at least 8 h. Fasting venous blood samples were
drawn for haemoglobin, creatinin and lipid profile. The rela-
tives brought an early morning urine sample for quantitative
measurements of albuminuria and dipstick urine analysis.
They stayed in a quiet room and the blood pressure was mea-
sured three times after a 5-min rest in sitting position using an
OMRON 705CP automatic oscillometric blood pressure de-
vice. The cuff was placed at the right upper arm. If the cir-
cumference of the arm exceeded 32 cm, a large cuff was used.
The weight and height were recorded while wearing. under-
wear. Also the circumference of the waist and hip were mea-
sured. If the relatives did not use anti-diabetic medication, an
OGTT was done with 75 g of glucose and the fasting glucose
äs well äs 2-h glucose was measured. The renal function was
estimated using the Cockcroft-Gault estimation [13]. We used
a questionnaire to obtain data on general demographic vari-
ables (age, sex, educational level and marital Status) family
history of diabetes mellitus in first-degree relatives (age of
onset, duration, treatment), hypertension, smoking and medi-
cation.
Laboratory measurements
Urinary albumin and protein were measured by immunoturbi-
dimetric assay on a Hitachi 911, äs was the HDL-cholesterol in
serum. Glucose, creatinin, cholesterol and triglycerides were
measured on a Hitachi-747 (Hitachi Tokyo, Japan). HbA|C was
measured using the HPLC method with a Variant analyser
(Biorad, Hercules, Calif., USA). The Variance Coefficient was
1.5% at different levels. The reference values for HbAk, are
between 4.3 and 6.3%. Urine dipstick investigation for leuko-
cyturia and hematuria was done with patch test strips using re-
flectance photometry with a Miditron photometer (Boehringer
Mannheim-Roche, diagnostics) [14].
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Outcome raeasurements
Patients who currently used oral atiti-diabelics or msulin were
classiiied äs known diabetic patients All other patients hdd a
glucose tolerance testmg (GTT) usmg the classic WHO cntena
[15] It the tastmg blood glucose was higher than 7 8 mmol/1
01 2 h GTT value was highei than 11 l mmol/1, patients were
coded äs de novo diabetic paticnts If the fastmg blood glucose
was below the 7 8 mmol/1 and 2 h GTT value was bctween
7 8-11 l mmol/1 they weie codcd äs impancd glucose toler-
ance If the 2 h GTT value was below the 7 8 mmol/1, patients
were classified äs normoglycaemic Unne albumin concentra
tion was measured m relation to the creatmin and expiessed äs
a ratio oi albumin/creatmm m mg/mmol Microalbummuria
was defmed accordmg to the diabetic Standards Normoalbu
minuna was present if the albumin to creatmin ratio was less
than 2 5 m men and less than 3 5 in women Microalbummuria
was present if the ratio was between 2 5 and 16 for men and
between 3 5 and 40 for women Protemuna was defmed if the
ratio was above 36 for men and 40 for women The renal func-
tion was estimated usmg the Cockcroft-Gault tormula and nor-
malized for BSA of l 73 m2 The resulls of the urme dipstick
weie measured usmg qualitative test stups which weie coded
usmg an automated photometnc reader Lcukocytuna was reg-
isteied äs absent, trace or positive, haematuna was registered
äs absent, trace 01 positive Dunng this visit, patients showed
then medications In case the paüent foigot to bring the pre
scnbcd medication or medication caid, the GP was contactcd
for the cxact medication Patients who did not use antihypei-
tcnsive medication were coded äs normotcnsivc if the averagc
blood pressute leadmgs weie below the 160 mmHg systohc
and below the 90 mmHg diastohc Borderhne hypertensive
profüe was defmed äs diastohc blood piessure leadmgs be
twcen 90 to 95 mmHg and systohc blood pressure below the
160 mmHg If patients used antihypertensive medication 01
had average blood pressure readmg above the 160 mmHg sys
tohc 01 95 mmHg diastohc they were registered äs hypeiten
sive profile
Statistical analysis
The calculations for the study si?e were based on a mmimally
detectable relative nsk of 3 foi microalbummuua in relatives
of Indo Asian diabetic patients with renal failurc comparcd
with Indo Asian diabetic patients without icnal failurc, with a
type l ciror ot 0 05 and a power of 0 90 Based on studies m
the United Kingdom [91 and the Netherlands [11] we assumed
the diabetes melhtus prevalence m Indo Asian famihes at
20-30% Assummg a pievalence of microalbuminuna m the
family membeis of the controls at 7%, 150 relatives have to be
mcluded in each tamily group (of whom about 40 would ex
pect to suffer from diabetes melhtus) Foi statistical compan
son of the difference öl means e g age, dmation of the diabe
tes, laboratory values between the case and control group, the
Student t test was used, the measmed difference of the means
were expressed with 95% confidence mleivals and p values
Differences of categorical variables like glucose tolerance,
urme dipstick measurements were expressed äs percentage dif
ference with 95% contidence mtervals and äs Chi-square/? val-
ues A p value of 0 05 or less was considered statistically sig
mficant
Results
Recruitment of Index-patients The recrmtment of the
index patients is shown m Table l We contacted 57
tndex patients with Type 2 diabetes melhtus and end-
stage diabetic nephropathy Of these patients 20 were
not ehgible 4 could not be leached by lelephone or by
mail, l had no potential relatives foi mvestigation,
and 15 patients did not give permission to contact
their relatives, leavmg 37 case-mdex patients
We contacted 132 control-mdex patients with Type 2
diabetes melhtus and no microalbummuua accordmg
to the records of the GP's We could not reach 26 pa
tients because they did not respond to our mvitation
and could not be reached by phone Fifteen patients
had no fnst-degree relatives living in the Netheilands
and 31 contiol-mdex patients did not give approval to
contact their relatives We therefore investigated 60
mdex control patients Seventeen index control pa-
tients were excluded afterwards because they had
microalbuminuna, leavmg 43 ehgible control-mdex
patients tor the study
Basic charactenstics of the case- and control-mdex
paticnts are givcn m Tablc 2 The age at mclusion in
our mvestigation was slightly higher m the case-mdex
patients group than in control index group The case-
mdex patients with end-stage diabetic nephropathy
also had a longer duration of diabetes disease than the
control-mdex patients who had no nephropathy (dif
ference 4 6 years with 95% CI 0 9 to 8 4) The index
patients with diabetic nephropathy were more often
treated with msuhn theiapy
Recruitment of first-degree relatives The recruitment
of the 330 fust-degree (siblings, children, parents) rela
tives was similai in famihes of index-case and mdex-
contiol patients Recruitment was done m 37 case fam-
ihes and 43 control famihes The leasons and numbeis
Table l Rcciuitment and dropout reasons o( the index paticnts
Case mdex patients Contiol mdex patients
Contacted index patients
Index patients not teachcd
No potential family mcmbeis
No Informed consent
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Table 2. Basic characteristics of the eligible index patienls with Type 2 diabetes mellitus
Case-index patients Control-index patients Difference (95% CI)
Number
Men n (%)
Age at inclusion investigation (years)
Agc at diagnosis diabetes (ycars)














1 (-20 to 23)
3.6 (-1.2 to 8.5)
-0.3 (-5.64 to 5.1)
4.6 (0.9 to 8.4)
13.4 (8.3 to 34.9)
Table 3. Basic characteristics of first-degree relatives of diabetic index patients with and without nephropathy. The characteristics
are expressed äs means, unless otherwise stated
Case-relatives Control-relatives Difference (95% CI) p value
Age
Male (%)
Body raass index (kg/m2)

















































0.8 (-1.8 to 3.3)
-6.8 (-17.5 to 3.7)
-0.07 (-1.1 toO.9)
-0.04 (-0.1 toO.06)
-0.01 (-0.03 to 0.2)
0.1 (-0.13lo0.3)
-0.03 (-0.3 to 0.2)
-0.17(-0.5to0.1)
-0.1 6 (-0.5 toO.2)
4.9 (-1.6to 11.5)
-1.7 (-8.1 io4.7)
2.9 (-7.4 to 13.2)
-6.2 (-13.7to 1.4)
-0.1 (-5.8 to 7.6)
34.7 (8.2 to 6 1.3)
0.5 (-4.6 to 5.5)











of patients who did not participate in the study were
distributed equally between the case and control group.
In the case group 234 relatives were approached; 65 pa-
tients (27.8%) declined or were unreachable, giving
165 case relatives for our investigation. In the control
group 221 relatives were approached; 60 patients
(27.2%) declined or were unreachable, giving 161 con-
trol relatives for the present investigation.
Characteristics of the relatives. The basic characteris-
tics are displayed in Table 3. Mean age was similar in
the case and control families, about 41 years. There
was a female preponderance in both family groups.
Mean BMI, body surface area, waist to hip ralio mea-
surements and lipid profiles were equal in the case
and control relatives. In the case-family members, 19
(11.2%) were known diabetic patients. The amount of
known diabetic relatives in the control-family mem-
bers was higher («=28; 17.4%). The results of the glu-
cose tolerance testing according to the WHO criteria
among the remaining relatives were similar.
Life style characteristics of the 330 relatives are
shown in Table 4. There were no differences in num-
bers of smokers between the case- and control-rela-
tives. There were slightly more subjects with vegetari-
an eating habits and Muslim religious attitudes in the
control families. The level of education was distribut-
ed equally in both case- and control-relative family
groups. The number of divorced persons was consid-
erably higher than in the case group.
Blood pressure profiles and treatments are givcn in
Table 5. The mean blood pressure measurements were
equal in both the case and control relatives. Antihyper-
tensive medical treatment was used in 13% of the case
relatives and 15% of the control relatives. The distribu-
tion of the type of antihypertensive meclication was not
different in both groups, especially for the ACE-inhibi-
tor and Angiotensin 2 receptor blockers usage.
Clinical features of renal disease in first-degree
relatives. The features of renal disease are given in
Table 6. No differences were detected in the distribu-
tion of microalbuminuria and proteinuria among the
case and control relatives. Subgroup analysis for dia-
betic state according to the WHO criteria also showed
no differences for microalbuminuria between the two
family groups. Also serum creatinin values and esti-
mated renal clearances were equal in both groups.
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Vegetarian eating pattern (%)
No
Only no meat or fish


























































4 2 f - 6 4 t o 147)
11.6 (5.2 to 18.0)
12.2 (2.3 to 22.1)
44(-44to 133)
4 2 ( - 2 4 t o 130)
-60 (-163to 5 3)
-2 9 (-9 9 to 3 9)
-11.4 (-22.1 to -0.6)
-1 8 (-11 1 to75)
0 9 (-3 9 to 5 8)
10.7 (2.5 to 18.8)







Table 5. Blood pressuie and treatment of hypertension in 330 farmly relatives
Systolic blood pressure (mean, mmHg)
Diastohc blood pressuie (mean, rnmHg)







































0 5 (-4 1 to 5 1 )
-04 (-284to 2 1)
0 1 (-9 5 to 9 6)
1 8 (-4 8 to 9 6)
-1 9 ( - 9 4 t o 5 6 )
3 9 (-136to 21 4)
-50 (-11 8to 1 7)






In general, there was no diffeience in dipstick lead-
ings between the case and control relatives
Discussion
In this population-based famüy study, we found no
diffeience m thc pievalence of nephropathy m family
members oi Indo-Asian Type 2 diabetic paüenls with
and without nephiopathy
Recently, we leported a close to 40-fold higher nsk
of end-stage nephropathy due to Type 2 diabetes melh-
tus m Sunnamese Indo-Asian immigrants when corn-
pared to native Dutch subjects [8] This is much higher
than the eight-time higher prevalence of diabetes [11]
m this population This suppoits the hypothesis of a
higher susceptibility to develop diabetic nephiopathy
m the Indo-Asian diabetic population Another possi-
bility is faster progiession oi diabetic nephropathy
toward end slage renal failure m Indo-Asian diabetic
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Table 6. Clinical features of renal di&ease in 330 first degree relatives of Type 2 diabetic palients with and without diabetic neph-
ropathy






































0.1 (-6.7 to 6.9)
1.0 (-3.1 toS.O)
-1.9 (-6.4to 2.5)
2.7 (-5.7 to 11.1)
4.5(-1.3to 10.2)
-7.2 (-13.8 to -0.53)
_4.4 (-14.610 5. 8)
5.1 (-3.710 13.8)






patients. Earlier studies for progression of nephropathy
in Indo-Asian diabetic patients were not conclusive
[16, 17]. An ethnic predisposition for renal diseases
can emerge in two ways: a general susceptibility of the
entire Indo-Asian population or a familial predisposi-
tion for renal diseases within certain Indo-Asian fami-
lies. The latter would point towards shared environ-
mental risk factors in these families or could indicate
susceptibility genes for nephropathy which are inherit-
ed independently from diabetes mellitus.
We investigated nephropathy in first-degree rela-
tives of Indo-Asian Type 2 diabetic patients who had
end-stage diabetic nephropathy necessitating dialysis
treatment or in whom preparations for dialysis were
made. As controls we invited first degree relatives of
Indo-Asian Type 2 diabetic patients who did not have
microalbuminuria. Despite the fact that we took the
most pronounced renal disease patients äs case-index
patients, we did not detcct differences in renal discase
in their relatives, defined by micro-albuminuria, glom-
crular filtration rates and blood pressures. The familial
predisposition for Type 2 diabetes measured by GTT
was similar in both the case and control relatives.
There were no differences in the prevalence of newly-
discovered diabetic patients and impaired glucose
tolerance test. Diabetic state, blood pressure profiles,
and anti-hypertensive treatment were the same in both
groups. Urine dipstick measurement for leukocyturia
and haematuria were similar in the case and control
relatives. A diffcrencc was notcd in religions. The
control group had somewhat more Muslims than Hin-
dus which could explain the slightly higher percentage
of vegetarians in the control group. However, this
could only lead to less proteinuria in the control
group.
The main advantage of our study is the investiga-
tion of all the diabetic family members, including pre-
viously unidentified diabetic family relatives. This ap-
peared to be important because for every known dia-
betic relative, a new diabetic relative was discovercd.
Diabetes was the strengest risk factor for renal disease
in both family groups. To prevent bias we randomly
selected the control-index patients using the records of
GP's of our case-index patients. Furthermore, we in-
vited the relatives of the case families and control
families in the same way.
The findings in our study are different from other
studies in other ethnic populations with Type 2 diabetic
patients. In American Pima Indians, there is a higher
risk of diabetic nephropathy in diabetic siblings and
offspring if the index patient had diabetic nephropa-
thy. [2] This was also found in families of Afro-Ameri-
can, Italian and Brazilian patients with Type 2 diabetes
[4, 5, 6, 7]. However, the results of these studies can-
not be extrapolated directly to the Indo-Asian popula-
tion living in the Netherlands. Firstly, most studies
were done with relatives of known diabetic patients
only äs control subjects. To study the hypothesis of fa-
milial nephropathy, we also took the results of newly-
discovered diabetic family members into account. Sec-
ondly, nearly all studies used proteinuric diabetic pa-
tients äs case-index patients. We investigated relatives
of case-index patients on dialysis treatment, giving a
strenger contrast with the relatives of control-index pa-
tients. It could be argued that the number of diabetic
patients in our study was not large enough to have suf-
ficienl power for detecting a clustering of diabetic
nephropathy. However, given perfect equality in the
degree of albuminuria and the prevalence of nephropa-
thy patients in both groups, it is difficult to imagine
that this would dramatically change with a larger sam-
ple size.
In summary, we did not find familial clustering of
renal disease in families of Type 2 diabetic patients
with end-stage diabetic nephropathy. In an earlier
study the much higher incidence of diabetic nephropa-
thy in Indo-Asians is not simply due to the higher in-
cidence of diabetes. The "gap" between the 40-fold
624 P K Chdndic Shaw et dl Renal disease in relatives of Indo-Asian Type 2 diabetic paticnts
increase m diabetic nephropathy and the only 8-fold
mciease of diabeles itseli may mean that all peisons
ot Indo-Asian descent are especially vulnerable to de-
velop nephropathy once they have developed diabetes
melhtus Anothei possibihty is faster progiession of
nephiopathy until end-stage diabetic nephropathy m
this population
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